Back to Hompage
Hebrew  |  English  
 
 
     
 
 
Homepage
Printer Friendly Version    
  My TASE  
 
CAN FITE BIOPHARMA LTD
Market Data Charts Historical Prices Statistics Profile Analysis & Ratios Disclosures
www.canfite.com
   Issuer No.   
Corporate No.
   Market Cap (25/05/2017)   
   1272   
   512022153   
    112,736 NIS thousands   
   TASE Supersector
   TASE Sector   
   TASE Subsector   
   Indices   
   High-Tech   
   Biomed   
   Biotechnology   
   TA-SME60, TA-Biomed Index, TA Global-BlueTech, TA-AllShare, TA-Rimon, TA-SME150, Additional Indices   
  Contact Details :
  Phone : 03-9241114
  Fax : 03-9249378
  MOTTI@CANFITE.CO.IL
   Interested Parties:
   Interested Parties:
List of Interested Parties  >
List of Securities  >
Indices  >
Index Adjusted Data for Company Securities  >
Financial Statements – Key Data (NIS thousands) **
 Yearly 2016Yearly 2015
Balance Sheet
Total Assets
39,109
68,708
Current Assets
38,867
68,445
Non Current Assets
242
263
Shareholders Equity
14,902
40,773
Of which Minority Interest
33
504
Current Liabilities
9,629
6,939
Long-Term Liabilities
14,578
20,996
Profit & Loss Statement
Revenues
652
643
Gross Profit
652
643
Operating Income
-33,211
-25,042
Income Before Tax
-26,897
-19,753
Net Income
-27,009
-19,770
Income Attributable to Shareholders
-27,486
-20,814
Earnings per Share
-0.96
-0.81
Additional Data
Dividends
---
0
Net cash flow generated by operating activities
---
-18,159
Financial Ratios
Market to book value
7.58
---
Price-Earning Ratio
Loss
---
Equity-Assets Ratio
38.0 %
58.6 %
Return on Equity
-99.7 %
-63.6 %
 Export Table Data 
Note: The financial statements data have been obtained from A-Online and they were compiled and processed by it. The data have not been examined or audited by the Stock Exchange and they are presented as given to the Stock Exchange by A-Online.
The binding data are those appearing in the financial statements published by the Company. Without derogating from the provisions of the use agreement , the Stock Exchange is not liable for any fault, error, mistake or inaccuracy in the data presented. Financial statements published in foreign currency are translated to NIS according to the exchange rate at the date of the financial statements.
Financial Ratios: Market Capitalization – as of end of previous trading day; Net income – attributable to the Shareholders (Trailing Twelve Months); Shareholders' Equity- attributable to the Shareholders (average 12 months start and end of period).